Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1983;68:1247-1253

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horowitz, J. D.
Right arrow Articles by Smith, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horowitz, J. D.
Right arrow Articles by Smith, T. W.

Circulation, Vol 68, 1247-1253, Copyright © 1983 by American Heart Association


ARTICLES

Potentiation of the cardiovascular effects of nitroglycerin by N- acetylcysteine

JD Horowitz, EM Antman, BH Lorell, WH Barry and TW Smith

The biochemical basis of the mechanism of vasodilatation by nitroglycerin (NTG) has not been previously investigated in man. However, evidence from in vitro studies suggests that NTG induces activation of guanylate cyclase via a series of enzymatic reactions that are modulated by the availability of sulfhydryl groups. Cysteine appears to be particularly effective in potentiating guanylate cyclase activation by NTG. To determine whether hemodynamic responsiveness to NTG in man might be modulated by sulfhydryl availability, concentration- response curves for effects of intravenously infused NTG on mean arterial pressure (MAP) and mean pulmonary capillary wedge pressure (PCW) were obtained in 10 patients undergoing cardiac catheterization for investigation of chest pain. NTG infusion was repeated 10 min after the intravenous infusion of 100 mg/kg of the cysteine source N- acetylcysteine (NAC). NAC induced no significant hemodynamic effect, but after NAC infusion there was a significant reduction both in the NTG infusion rate associated with a 10% fall from control values in MAP (25.8 +/- 8.3 to 9.3 +/- 2.7 micrograms/min; p less than .01) and in the infusion rate inducing a 30% reduction in PCW (13.6 +/- 4.6 to 4.2 +/- 1.6 micrograms/min; p less than .02). In a control group of five patients who received no NAC, there was no significant change in responsiveness to NTG between infusions. It is concluded that NAC potentiates the vasodilator effects of NTG in man. This suggests that sulfhydryl availability and/or redox state may be determinants of in vivo responsiveness to NTG.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. D. Horowitz
Amelioration of nitrate tolerance: matching strategies with mechanisms
J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2001 - 2003.
[Full Text] [PDF]


Home page
CirculationHome page
J. Loscalzo
Folate and Nitrate-Induced Endothelial Dysfunction: A Simple Treatment for a Complex Pathobiology
Circulation, September 4, 2001; 104(10): 1086 - 1088.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. P. Andrews, A. Prasad, and A. A. Quyyumi
N-acetylcysteine improves coronary and peripheral vascular function
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 117 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. O'Byrne, C. Shirodaria, T. Millar, C. Stevens, D. Blake, and N. Benjamin
Inhibition of Platelet Aggregation with Glyceryl Trinitrate and Xanthine Oxidoreductase
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 326 - 330.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
A. Prasad, N. P. Andrews, F. A. Padder, M. Husain, and A. A. Quyyumi
Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 507 - 514.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W.-M. Sun, S. Doran, K. L. Jones, E. Ooi, G. Boeckxstaens, G. S. Hebbard, T. Lingenfelser, J. E. Morley, J. Dent, and M. Horowitz
Effects of nitroglycerin on liquid gastric emptying and antropyloroduodenal motility
Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G1173 - G1178.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. F. Kearney, J. F. Brien, G. S. Marks, H. Lei, and K. Nakatsu
Thiol Agents Separate Nitric Oxide Formation from Vasodilation Induced by Glyceryl Trinitrate
Drug Metab. Dispos., June 1, 1998; 26(6): 547 - 551.
[Abstract] [Full Text]


Home page
NEJMHome page
J. D. Parker and J. O. Parker
Nitrate Therapy for Stable Angina Pectoris
N. Engl. J. Med., February 19, 1998; 338(8): 520 - 531.
[Full Text] [PDF]


Home page
CirculationHome page
M. A. Arstall, J. Yang, I. Stafford, W. H. Betts, and J. D. Horowitz
N-Acetylcysteine in Combination With Nitroglycerin and Streptokinase for the Treatment of Evolving Acute Myocardial Infarction : Safety and Biochemical Effects
Circulation, November 15, 1995; 92(10): 2855 - 2862.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
U. Elkayam
Tolerance to Organic Nitrates: Evidence, Mechanisms, Clinical Relevance, and Strategies for Prevention
Ann Intern Med, April 15, 1991; 114(8): 667 - 677.
[Abstract] [PDF]